RBC Capital initiated coverage of Bicycle Therapeutics with an Outperform rating and $35 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BCYC:
Questions or Comments about the article? Write to editor@tipranks.com